People at highest risk of serious illness from SARS-CoV-2 infection may soon have access to better shielding advice based on a new data-driven risk prediction model being developed by an Oxford University-led team. The Principal Investigator, Professor Julia Hippisley-Cox of the ... READ MORE
News
Breakthrough in RECOVERY COVID-19 drug treatment trial
A cheap and widely available steroid has been found to save lives of patients hospitalised with COVID-19 in a national trial being led by University of Oxford researchers. Dexamethasone was one of the drugs being tested as part of the RECOVERY trial, the world's biggest trial looking at whether ... READ MORE
Oxford BRC achieves ISO 9001 audit success
Following an external audit, the NIHR Oxford Biomedical Research Centre (BRC) has again been successfully certified to the internationally recognised ISO 9001:2015 standard. Oxford is the only NIHR BRC in the country to have designated ISO 9001 ... READ MORE
Serum iron may be useful biomarker to identify COVID-19 disease severity
A new study led by University of Oxford researchers has found that patients with severe COVID-19 respiratory failure have very low levels of iron, compared to those with less severe disease. Changes in iron levels have been associated with worsening disease for other viral infections such ... READ MORE
Study explores effects of COVID-19 on sleep
Oxford researchers have launched a study investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults. The UK arm of the International COVID-19 Sleep Study (ICOSS) is led by Professor Colin Espie from the Nuffield Department of Clinical Neurosciences at the University ... READ MORE
Oxford leads part of major COVID-19 drugs trial
As part of a new UK trial researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death. The multi-arm, multi-stage CATALYST Trial, is being led by the ... READ MORE
Oxford BRC researchers present findings as STARBIOS2 ends
Oxford BRC-funded researchers have presented important new findings in the field of gender equity and women in Biomedical Research Centres at the final event of the international STARBIOS2 project. Started in 2016, STARBIOS2 (Structural Transformation to Attain Responsible BIOSciences) is a ... READ MORE
First patient recruited for key drug treatment trial
A clinical trial to test whether Azithromycin, a commonly used antibiotic, can treat the symptoms of COVID-19 in outpatients has recruited its first patient. The ATOMIC2 trial, which is being led from Oxford, will enrol 800 people who are being assessed at hospital with COVID-19 but felt well ... READ MORE
Drug trial could lead to enhanced respiratory care for COVID-19 patients
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals, including Oxford University Hospitals, to test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen levels is ... READ MORE
Study sheds light on breast cancer risk after pre-invasive disease
Women who are diagnosed with ductal carcinoma in situ (known as DCIS) during breast screening go on to experience higher risks of developing breast cancer and of death from breast cancer, compared with the general population, according to a study by Oxford researchers. DCIS is a disease where ... READ MORE
- « Previous Page
- 1
- …
- 41
- 42
- 43
- 44
- 45
- …
- 93
- Next Page »